New-onset maternal gestational hypertension and risk of retinopathy of prematurity

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 10, 2010, Pages 4983-4988

  Zayed, Mohamed A ^a   Uppal, Abhineet ^a   Elizabeth Hartnett, M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN;

BIRTH WEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECLAMPSIA; FEMALE; GESTATIONAL AGE; HELLP SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; NEWBORN; PREECLAMPSIA; PREMATURITY; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; REVIEW; RISK FACTOR; ARTICLE; CLASSIFICATION; ERYTHROCYTE TRANSFUSION; LOW BIRTH WEIGHT; NEWBORN ANEMIA; PREGNANCY; RETROSPECTIVE STUDY;

ANEMIA, NEONATAL; ERYTHROCYTE TRANSFUSION; ERYTHROPOIETIN, RECOMBINANT; FEMALE; GESTATIONAL AGE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; PREGNANCY; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77958117380     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5283     Document Type: Review

References (29)

1. Gilbert C, Rahi J, Eckstein M, O'Sullivan J, Foster A. Retinopathy of prematurity in middle-income countries. Lancet. 1997;350:12-14.
2. Section on Ophthalmology American Academy of Pediatrics, American Academy of Ophthalmology, and American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity [published correction appears in Pediatrics. 2006;118:1324]. Pediatrics.2006;117:572-576.
3. Hellstrom A, Hard AL, Engstrom E, et al. Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening. Pediatrics. 2009;123:e638-e645.
4. Walker JJ. Pre-eclampsia. Lancet. 2000;356:1260-1265.
5. Srinivas SK, Edlow AG, Neff PM, et al. Rethinking IUGR in preeclampsia: dependent or independent of maternal hypertension? J Perinatol. 2009;29:680-684.
6. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672-683.
7. Signore C, Mills JL, Qian C, et al. Circulating soluble endoglin and placental abruption. Prenat Diagn. 2008;28:852-858.
8. Grill S, Rusterholz C, Zanetti-Dallenbach R, et al. Potential markers of preeclampsia: a review. Reprod Biol Endocrinol. 2009;7:70.
9. Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonata Med. 2008;21:9-23.
10. McColm JR, Hartnett ME. Retinopathy of prematurity: current understanding based on clinical trials and animal models. In: Pediatric Retina. Philadelphia: Lippincott, Williams & Wilkins; 2005; 387-409.
11. Shah VA, Yeo CL, Ling YL, Ho LY. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann Acad Med Singapore. 2005;34:169-178.
12. Seiberth V, Linderkamp O. Risk factors in retinopathy of prematurity: a multivariate statistical analysis. Ophthalmologica.2000;214:131-135.
13. Ohlsson A, Aher SM. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants (review). Cochrane Database Syst Rev. 2006;3:CD004863.
14. Aher SM, Ohlsson A. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants (review). Cochrane Database Syst Rev. 2006;3;CD004865.
15. Suk KK, Dunbar JA, Liu A, et al. Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model. J AAPOS. 2008;12:233-238.
16. Brown MS, Baron AE, France EK, Hamman RF. Association between higher cumulative doses of recombinant erythropoietin and risk for retinopathy of prematurity. J AAPOS. 2006;10:143-149.
17. Chen J, Connor KM, Aderman CM, Smith LE. Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest. 2008;118: 526-533.
18. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of pre-maturity randomized trial. Arch Ophthalmol. 2003;121:1684-1694.
19. International Committee. An international classification of retinopathy of prematurity. Br J Ophthalmol 1984;68:690-697.
20. Barker DJ. In utero programming of chronic disease. Clin Sci (Lond). 1998;95:115-128.
21. Roberts JM. Preeclampsia: what we know and what we do not know. Semin Perinatol. 2000;24:24-28.
22. Roberts JM, Rajakumar A. Preeclampsia and soluble fms-like tyrosine kinase 1. J Clin Endocrinol Metab. 2009;94:2252-2254.
23. Yang JC, Haworth L, Sherry RM, et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med. 2003;349:427-434.
24. Lu F, Bytautiene E, Tamayo E et al. Gender-specific effect of overexpression of sFlt-1 in pregnant mice on fetal programming of blood pressure in the offspring later in life. Am J Obstet Gynecol.2007;197:418-415.
25. Lu F, Longo M, Tamayo E, et al. The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am J Obstet Gynecol. 2007;196:396-397.
26. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649-658.
27. Cryotherapy for Retinopathy of Prematurity Cooperative Group. The natural ocular outcome of premature birth and retinopathy: status at 1 year. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol. 1994;112:903-912.
28. Hadi HA, Hobbs CL. Effect of chronic intrauterine stress on the disappearance of tunica vasculosa lentis of the fetal eye: a neonatal observation. Am J Perinatol. 1990;7:23-25.
29. Arjamaa O, Nikinmaa M. Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors. Exp Eye Res. 2006;83:473-483.